News Focus
News Focus
icon url

DewDiligence

06/30/16 9:35 PM

#12792 RE: DewDiligence #12790

MDLZ offered $23B, but HSY said no:

http://finance.yahoo.com/news/abbvies-humira-adalimumab-receives-u-002600396.html

No company accepts the first unsolicited offer.

Unusual wrinkle: A charitable trust has voting control of HSY.